Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Pulmonary Tuberculosis”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Testing effectiveness (Phase 2)WithdrawnNCT00374517
What this trial is testing

Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected Lungs

Who this might be right for
Refractory Pulmonary Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID)
Testing effectiveness (Phase 2)WithdrawnNCT01528930
What this trial is testing

Inhaled Amikacin Treatment for Nontuberculous Mycobacterial Lung Disease

Who this might be right for
Pulmonary Non-tuberculous Mycobacterial Lung Disease
Samsung Medical Center
Not applicableUnknownNCT02816229
What this trial is testing

Endobronchial Valves in Inoperable Patients With Haemoptysis

Who this might be right for
Haemoptysis
University of Stellenbosch 20
Large-scale testing (Phase 3)Ended earlyNCT06418711
What this trial is testing

ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung DiseaseMycobacterium Infections, Nontuberculous
Mannkind Corporation 132
Not applicableUnknownNCT02878447
What this trial is testing

The Utility of Radiotherapy in the Management of Haemoptysis Secondary to Aspergillomata and Structural Lung Diseases

Who this might be right for
Haemoptysis
University of Stellenbosch 40
Testing effectiveness (Phase 2)Ended earlyNCT01131351
What this trial is testing

Safety and Pharmacokinetics (PK) in Multidrug-Resistant (MDR) Refractive Tuberculosis

Who this might be right for
Tuberculosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 10
Large-scale testing (Phase 3)Ended earlyNCT05327803
What this trial is testing

Study of Epetraborole in Patients With Treatment-refractory MAC Lung Disease

Who this might be right for
MAC Lung DiseaseTreatment Refractory MAC Lung Disease
AN2 Therapeutics, Inc 177